ClinicalTrials.gov
public full text
Public Domain
Effect of Circulating lncRNAs on Type 2 Diabetic Peripheral Neuropathy
This project intends to use high-throughput sequencing, molecular biology and bioinformatics technology to clarify the role of target lncrnas in the inflammatory response of DPN, to explore the correlation between target lncrnas and DPN pathogenesis, and to clarify the feasibility of target lncrnas as a marker of DPN cycle.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- lncAPNet enables the deciphering of lncRNA-mRNA connections in patient transcriptomic data.#469100
- A First-in-human Clinical Trial Using a Gene Therapy With Patient's Own Stem Cells to Treat Early Type 1 Diabetes#826307
- Astrocytes as Therapeutic Targets in Neurodegenerative Disorders#1146122
- Ginsenoside Rg1 Attenuates Neuroinflammation in Parkinson’s Disease Models via Concomitant Modulation of Canonical and Noncanonical Wnt Pathways in Microglial M1/M2 Polarization#440504
- A Study of LY3209590 in Healthy Participants and Participants With Type 2 Diabetes#257064
Record · ID 1137845
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive